Cleveland BioLabs Inc.

(CBLI) Trade

By |

Profile

Cleveland BioLabs Inc is a biopharmaceutical company. The company is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Cleveland's lead product candidate is entolimod, an immuno-stimulatory agent, which is developed as a radiation countermeasure and an immunotherapy for oncology and other indications. Entolimod is a Toll-like receptor 5 (TLR5) agonist, which is developed as a radiation countermeasure for prevention of death from Acute Radiation Syndrome (ARS), and as an oncology drug.

Contact Information

Website: www.cbiolabs.com
Email: rlevine@cbiolabs.com
Main Phone: +1 716 849-6810
Address: 73 High Street
State: NY
City / Town: Buffalo
Country: USA
Postal Code: 14203

Issuer Information

Exchange: NSC
CEO: Yakov Kogan
Employees: 19
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)


Gathering Data... Please wait

Profile

Cleveland BioLabs Inc is a biopharmaceutical company. The company is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Cleveland's lead product candidate is entolimod, an immuno-stimulatory agent, which is developed as a radiation countermeasure and an immunotherapy for oncology and other indications. Entolimod is a Toll-like receptor 5 (TLR5) agonist, which is developed as a radiation countermeasure for prevention of death from Acute Radiation Syndrome (ARS), and as an oncology drug.

Contact Information

Website: www.cbiolabs.com
Email: rlevine@cbiolabs.com
Main Phone: +1 716 849-6810
Address: 73 High Street
State: NY
City / Town: Buffalo
Country: USA
Postal Code: 14203

Issuer Information

Exchange: NSC
CEO: Yakov Kogan
Employees: 19
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)
$ 1.46 $ -0.03 (-2.01%)
Last Price 1.46 Change $ -0.03 Change % -2.01 Tick N/A
Bid 1.00 Bid Size 100.00 Ask 1.56 Ask Size 400.00
Open 1.47 High 1.47 Low 1.43 Prev Close 1.49
Last Trade Volume 2,478 52 Wk Hi 4.01 52 Wk Low 1.00
Market Cap 16.5 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 11,298,239.00 EPS (TTM) -0.40 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Randy S. Saluck 1,000
Paul E. Dicorleto 1,000
Randy S. Saluck 1,000
James J. Antal 1,000
James J. Antal 1,000
David C. Hohn 1,000
James J. Antal 1,000
David C. Hohn 1,000
James J. Antal 1,000
James J. Antal 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 2 2 2 2
Low Target Price Estimate 2 2 2 2
Mean Target Price Estimate 2 2 2 2
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 01/27/14 01/27/14 01/27/14 01/27/14
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 3